In February 2021, Royal Brompton and Harefield hospitals became part of Guy’s and St Thomas’ NHS Foundation Trust.
Working from two main sites, Royal Brompton Hospital in Chelsea, West London and Harefield Hospital near Uxbridge, we are the largest specialist heart and lung centre in the UK and among the largest in Europe.
Our experts are known throughout the world for their expertise, standard of care and research success.
Our specialist hospitals provide treatment for people with heart and lung disease, including rare and complex conditions. We carry out some of the most complicated surgery, and offer some of the most sophisticated treatment that is available anywhere in the world.
Among their many achievements, experts at Royal Brompton and Harefield hospitals:
- pioneered intricate heart surgery for newborn infants born with a congenital heart disease
- performed the first successful heart and lung transplant in Britain
- implanted the first coronary stent.
Research programmes play a vital role at both our hospitals. This is because the most talented medical experts are rarely content with using tried and tested methods to treat their patients.
The opportunity to influence the course of modern medicine by developing new treatments is a prospect that attracts them to specialist centres, where research opportunities are a fundamental part of delivering patient care. Many medical advances made at our hospitals have been taken up across the NHS and beyond.
Each year, between 500 and 600 papers by researchers associated with the hospitals are published in peer-reviewed scientific journals, such as The Lancet and New England Journal of Medicine.
Our main partner is the National Heart and Lung Institute at Imperial College, London. We run additional research projects with other hospitals and universities in the UK and abroad.
In 2019/2020 we:
- Cared for more than 216,000 patients in our outpatient clinics
- Cared for nearly 40,000 patients on all our wards
- Maintained one of the fastest arrival to treatment times for heart attack patients in the UK (23 minutes compared to a national average of 56)
- Launched Rainbow badges showing that the Trust offers open, non-judgemental and inclusive care for patients and their families and friends, who identify as LGBT+
- Received a 96 per cent recommendation score in the annual Friends and Family Test
- Reported an average 18-week referral to treatment time (RTT) of 93%, exceeding the national target
- Introduced sunflower lanyards which, when worn discreetly, indicate to staff that wearers have a hidden disability and may require additional support or assistance
- Built on our Day of Surgery pilot scheme with 70% of Harefield cardiac surgery patients admitted on the day of surgery, up from 3-4% when the pilot started
- Produced 886 peer-reviewed publications with our academic partners, strengthening the Trust’s position as a leading centre for cardiovascular, critical care and respiratory research
- Recruited over 2,300 patients onto over 100 research programmes that will contribute towards better patient care and outcomes
- Improved our communication to patients with the introduction of digital appointment letters and text reminders
- Improved our environmental responsibility by reducing our carbon emissions by 9% and our energy consumption by 2.7%